![Mark Mossler](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Mark Mossler
No más puestos en curso
Fortuna: 79 551 $ al 31/05/2026
Perfil
Mark Mossler worked as Senior Director-Global Accounting at BeOne Medicines Ltd. from 2017 to 2023.
Mr. Mossler worked as Chief Accounting Officer at C4 Therapeutics, Inc. from 2023 to 2026.
Mr. Mossler completed undergraduate and MBA degrees at Babson College.
Participaciones conocidas en empresas públicas
| Empresa | Fecha | Número de acciones | Valoración | Fecha de valoración |
|---|---|---|---|---|
C4 THERAPEUTICS, INC. 0,02 % | 14/02/2026 | 18.204 ( 0,02 % ) | 79 551 $ | 31/05/2026 |
Antiguos cargos conocidos de Mark Mossler.
| Empresas | Cargo | Fin |
|---|---|---|
| C4 THERAPEUTICS, INC. | Comptroller/Controller/Auditor | 15/05/2026 |
| BEIGENE LTD | Comptroller/Controller/Auditor | 01/06/2023 |
Formación de Mark Mossler.
Experiencias
Funciones ocupadas
Activas
Inactivas
Empresas cotizadas
Empresas privadas
Relaciones
11
Relaciones de 1er grado
3
Empresas vinculadas al 1er grado
Hombre
Mujer
Administradores
Ejecutivos
Empresas relacionadas
| Empresas privadas | 3 |
|---|---|
Babson College
 Babson College Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
BeiGene Ltd.
 BeiGene Ltd. Pharmaceuticals: MajorHealth Technology Develops biopharmaceutical products | Health Technology |
C4 Therapeutics, Inc.
 C4 Therapeutics, Inc. BiotechnologyHealth Technology Develops targeted protein degradation therapeutics for the treatment of cancer | Health Technology |
- Bolsa de valores
- Insiders
- Mark Mossler
